Andrew Wolf, MD
Assistant Professor, Neurology

Photo
Download CV
Medical School:
  • MD, University of Colorado Denver School of Medicine (2018)
Graduate School :
  • MS, University of Colorado Denver (2016)
Undergraduate School:
  • BS, Arizona State University (AZ) (2010)
Internship:
  • University of Colorado (2019)
Residency:
  • University of Colorado, Chief Resident, Neurology (2022)
Fellowships:
  • University of Colorado, Neuroimmunology (2023)
Languages: English
Department: Neurology

Research Interests

My research interests are focused on improving the treatment of patients with multiple sclerosis and other inflammatory diseases of the central nervous system. Current projects include developing digital and blood biomarkers to detect worsening in multiple sclerosis patients, characterizing clinical outcomes of neuroinvasive West Nile virus infection in patients on anti-CD20 treatments, and understanding the risks of immune checkpoint inhibitor use in patients with neuroimmunological disease. I am also interested in the acute management of demyelinating diseases and optimizing inpatient to outpatient care transitions.

Teaching

  • Associate Program Director, Neuroimmunology Fellowship (2023)
    School of Medicine, Neurology

Publications

  • Wolf AB, Money KM, Chandnani A, Daley CL, Griffith DE, Chauhan L, Coffman N, Piquet AL, Tyler KL, Zimmer S, Montague BT, Mann S, Pastula DM. Mycobacterium abscessus meningitis associated with stem cell treatment during medical tourism. Emerg Infect Dis. 2023 29:23-0317. DOI 10.3201/2908.230317.
  • Wolf AB, Alvarez E, Corboy JR. Comparative efficacy of disease-modifying treatments for relapsing multiple sclerosis - variations in real-world experience. JAMA Neurol. In press. DOI 10.1001/jamaneurol.2023.4395.
  • Wolf AB & Shah AA (2023). Clinical trials in multiple sclerosis. MedLink Neurology.
  • Shiao JC, Wolf AB, Rabinovitch RA, Smith C, Kleinschmidt-DeMasters BK, Ney DE. Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy. Adv Radiat Oncol. 2022 Mar-Apr;7(2):100831. PubMed PMID: 34934868
  • Wolf AB & Alvarez E. Ublituximab: A novel anti-CD20 therapy for multiple sclerosis. touchREVIEWS in Neurology. 2022. DOI: 10.17925/USN.2022.18.2.117
  • Shah AA, Wolf AB, Declusin A, Coleman K, Kammeyer R, Khan B, Corboy JR. Challenging Cases in Neuroimmunology. Semin Neurol. 2022 Dec;42(6):695-707. PubMed PMID: 36690027
  • Vollmer BL, Wolf AB, Sillau S, Corboy JR, Alvarez E. Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis. Front Neurol. 2021;12:799138. PubMed PMID: 35145470
  • Wolf A, Alvarez E. COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying Therapy. Neurol Clin Pract. 2021 Aug;11(4):358-361. PubMed PMID: 34484934
  • Wolf AB, Ryerson LZ, Pandey K, McGettigan BM, Vollmer T, Corboy JR, Alvarez E. Rituximab-induced serum sickness in multiple sclerosis patients. Mult Scler Relat Disord. 2019 Nov;36:101402. PubMed PMID: 31542710
  • Wolf AB & Felsen G. How public health policy can be informed by neuroscience. Behav Public Policy. 2019; 3: 37-46. DOI 10.1017/bpp.2017.9.
  • Kusne Y, Wolf AB, Townley K, Conway M, Peyman GA. Visual system manifestations of Alzheimer's disease. Acta Ophthalmol. 2017 Dec;95(8):e668-e676. PubMed PMID: 27864881
  • Perkins M, Wolf AB, Chavira B, Shonebarger D, Meckel JP, Leung L, Ballina L, Ly S, Saini A, Jones TB, Vallejo J, Jentarra G, Valla J. Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ?4 Carriers. J Alzheimers Dis. 2016 Apr 23;53(1):95-106. PubMed PMID: 27128370
  • Wolf AB, Lintz MJ, Costabile JD, Thompson JA, Stubblefield EA, Felsen G. An integrative role for the superior colliculus in selecting targets for movements. J Neurophysiol. 2015 Oct;114(4):2118-31. PubMed PMID: 26203103
  • Snyder LA, Wolf AB, Oppenlander ME, Bina R, Wilson JR, Ashby L, Brachman D, Coons SW, Spetzler RF, Sanai N. The impact of extent of resection on malignant transformation of pure oligodendrogliomas. J Neurosurg. 2014 Feb;120(2):309-14. PubMed PMID: 24313617
  • Oppenlander ME, Wolf AB, Snyder LA, Bina R, Wilson JR, Coons SW, Ashby LS, Brachman D, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity. J Neurosurg. 2014 Apr;120(4):846-53. PubMed PMID: 24484232
  • Hardesty DA, Wolf AB, Brachman DG, McBride HL, Youssef E, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg. 2013 Aug;119(2):475-81. PubMed PMID: 23394332
  • Wolf AB, Caselli RJ, Reiman EM, Valla J. APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease. Neurobiol Aging. 2013 Apr;34(4):1007-17. PubMed PMID: 23159550
  • Wolf AB, Valla J, Bu G, Kim J, LaDu MJ, Reiman EM, Caselli RJ. Apolipoprotein E as a ß-amyloid-independent factor in Alzheimer's disease. Alzheimers Res Ther. 2013;5(5):38. PubMed PMID: 23998393
  • Wolf AB, Braden BB, Bimonte-Nelson H, Kusne Y, Young N, Engler-Chiurazzi E, Garcia AN, Walker DG, Moses GS, Tran H, LaFerla F, Lue L, Emerson Lombardo N, Valla J. Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention. J Alzheimers Dis. 2012;32(1):217-32. PubMed PMID: 22796872
  • Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman MJ, Caselli RJ, Reiman EM. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE e4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis. 2010;22(1):307-13. PubMed PMID: 20847408
View All (20 Total) View Less

Practice Locations

UCHealth Neurosciences Center - Anschutz Medical Campus
1635 Aurora Ct
4th Floor
Aurora, CO 80045
720-848-2080

Denver Health
777 Bannock St
Denver, CO 80204
303-436-6000

Hospital Affiliation
  • University of Colorado Hospital
  • Denver Health Medical Center
Center Affiliations

Specialty Information

Specialties
  • Neurology, Board Certification (2022)
  • Neuroimmunology
Conditions & Treatments
  • Brain and Nervous System - Multiple Sclerosis
  • Brain and Nervous System
Clinical Interests
My clinical practice is focused on multiple sclerosis and other inflammatory disorders of the central nervous system including NMOSD, MOGAD, neurosarcoidosis, and CNS vasculitis.

Volunteer Activities
DAWN Clinic

General Information

Medical Schools:
  • MD, University of Colorado Denver School of Medicine (2018)
Graduate Schools:
  • MS, University of Colorado Denver (2016)
Undergraduate Schools:
  • BS, Arizona State University (AZ) (2010)
Internships:
  • University of Colorado (2019)
Residency Programs:
  • University of Colorado, Chief Resident, Neurology (2022)
Fellowships:
  • University of Colorado, Neuroimmunology (2023)
Download CV
Languages: English
Department: Neurology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;